Evidence map›Paper›PMID 37256130›Full record

ArticleFrontiers in immunology2023

Alex Yashchenko, Sarah J Bland, Cheng J Song, Ummey Khalecha Bintha Ahmed, Rachel Sharp, Isabella G Darby, Audrey M Cordova, Morgan E Smith, Jeremie M Lever, Zhang Li and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Neutrophil depletion exacerbatesFood and waterborne parasitology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Kidney resident macrophages have distinct subsets and multifunctional roles.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 2 countries.

Alex YashchenkoDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Sarah J BlandDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Cheng J SongDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States.
Ummey Khalecha Bintha AhmedDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Rachel SharpDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Isabella G DarbyDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Audrey M CordovaDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Morgan E SmithDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Jeremie M LeverDepartment of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, United States.
Zhang LiDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States.
Ernald J AloriaDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States.
Shuja KhanDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Bibi MaryamDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Shanrun LiuDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Michael R CrowleyDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Kenneth L JonesDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Lauren A ZenewiczDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
James F GeorgeDepartment of Surgery, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, AL, United States.
Michal MrugDepartment of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, United States.
David K CrossmanDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Katharina HoppDepartment of Medicine, Division of Renal Diseases and Hypertension, Polycystic Kidney Disease Program, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Stavros StavrakisDepartment of Internal Medicine, Division of Cardiovascular Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Mary B HumphreyDepartment of Internal Medicine, Division of Rheumatology, Immunology, and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Florent GinhouxSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos, Singapore, Singapore.
Kurt A ZimmermanDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
University of Oklahoma Health Sciences Center · USUniversity of Alabama at Birmingham · USAgency for Science, Technology and Research · SGUniversity of Colorado Anschutz Medical Campus · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Vascular-macrophage crosstalk in GBM immunosuppressionP20GM134973 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Sree Deepthi Muthukrishnan · 2020 to 2026
$17.6M
UAB Recessive PKD Research and Translational Core CenterP30DK074038 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 2005 to 2019
$16.6M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Research BaseP30DK090868 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2010 to 2019
$11.1M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC) - Therapeutic Development and Screening ResourceU54DK126087 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Bradley K. Yoder · 2020 to 2026
$6.7M
Mechanisms of C3 effects in ARPKD pathogenesisR01DK097423 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MRUG, MICHAL · 2013 to 2017
$1.6M
Targeting kidney resident macrophage niche filling to slow cystic kidney diseaseR01DK129255 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Kurt A Zimmerman · 2022 to 2026
$1.6M
Defining the functional role of T-cells in Autosomal Dominant Polycystic Kidney Disease pathologyK01DK114164 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HOPP, KATHARINA · 2018 to 2022
$783k
Investigating CD4 T regulatory cells during rapid cystogenesisK01DK119375 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ZIMMERMAN, KURT A · 2020 to 2023
$608k
BLRD VA I01 BX002298BLRD VA I01 BX004232NIAID NIH HHS P30 AI027767NIAID NIH HHS T32 AI007051NIAMS NIH HHS P30 AR048311NIDDK NIH HHS K01 DK114164NIDDK NIH HHS K01 DK119375NIDDK NIH HHS P30 DK074038NIDDK NIH HHS P30 DK079337NIDDK NIH HHS P30 DK090868NIDDK NIH HHS R01 DK097423NIDDK NIH HHS R01 DK129255NIDDK NIH HHS U54 DK126087NIGMS NIH HHS P20 GM134973
6 · The paper itself

Abstract

Kidney macrophages are comprised of both monocyte-derived and tissue resident populations; however, the heterogeneity of kidney macrophages and factors that regulate their heterogeneity are poorly understood. Herein, we performed single cell RNA sequencing (scRNAseq), fate mapping, and parabiosis to define the cellular heterogeneity of kidney macrophages in healthy mice. Our data indicate that healthy mouse kidneys contain four major subsets of monocytes and two major subsets of kidney resident macrophages (KRM) including a population with enriched

Indexed as

MacrophagesMonocytesAnimalsCX3C Chemokine Receptor 1Disease Models, AnimalKidneyMiceReceptors, ChemokineCX3C Chemokine Receptor 1Cx3cr1 protein, mouseReceptors, ChemokineCCR2CX3CR1cystic kidney diseasefate mappingkidney macrophagesmacrophage heterogeneityparabiosissingle cell RNA sequencing (scRNAseq)

Identifiers

PMID37256130
PMCPMC10225589
OpenAlexW4376612183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.